Dexamethasone for Ureteral STent Symptoms (DUSTS)

Part of paid clinical trials in Houston, Texas.

Sponsor
The Methodist Hospital Research Institute
Study ID
NCT06930690
Phase
PHASE1/PHASE2
Status
Recruiting

Conditions

  • Ureteral Stent-Related Symptom

Eligibility Criteria

Sex
ALL
Age
18 Years - 70 Years
Healthy Volunteers
Not accepted

Interventions

  • Dexamethasone Sodium Phosphate Injection 20 mg — DRUG
    dexamethasone 20 mg diluted in 50 mL of normal saline administered by intravenous drip after induction of anesthesia
  • Dexamethasone Sodium Phosphate Injection 4mg — DRUG
    dexamethasone 4 mg diluted in 50 mL of normal saline administered by intravenous drip after induction of anesthesia

Study Details

The purpose of this study to learn if high-dose dexamethasone, a type of long-acting steroid, works to decrease urinary symptoms and pain after ureteroscopy and stent placement for kidney stones. The main question it aims to answer is: 1\) Does high-dose steroid change the quality of life score on day 2 after surgery Researchers will compare high-dose of dexamethasone (20 mg) to a standard dose of dexamethasone (4 mg) to see if a higher dose of the drug will help with urinary symptoms and pain Participants will: 1. randomly receive 20 mg or 4 mg of dexamethasone (20 mg) at the time of surgery 2. fill out a questionnaire day 1 and day 2 after surgery 3. fill out a medication diary for one week after surgery 4. visit the clinic on day 2 after surgery for checkup 5. visit the clinic on day 4-7 after surgery for check up

Key Dates

Start date
Jun 30, 2026
Status verified
May 2026
Primary completion
Dec 31, 2026
Completion
Apr 30, 2027

Study Design

Enrollment
70 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: Treatment Arm
    Dexamethasone 20 mg
  • Active Comparator: Control Arm
    Dexamethasone 4 mg

Primary Outcome Measure

Global Quality of Life Score of Ureteral Stent Symptom Questionnaire (USSQ) [ Time Frame: Day 2 after surgery ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Houston Methodist HospitalHoustonTexas77005
Farida Tufail
713-269-0186
Monica Morgan, MD (PRINCIPAL_INVESTIGATOR)
Rose Khavari, MD (SUB_INVESTIGATOR)
Kathleen Kobashi, MD (SUB_INVESTIGATOR)

Find similar trials in Houston, TX

Related Studies